An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. - Wikidata - wikimedia - TriplyDB

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

http://www.wikidata.org/entity/Q34534186

about

Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family Antimicrobial peptides and the skin immune defense system The role of antimicrobial peptides in chronic inflammatory skin diseases Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides Vitamin D and the skin: Focus on a complex relationship: A review Depot-Based Delivery Systems for Pro-Angiogenic Peptides: A Review The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs Antiviral potential of cathelicidins The new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasis Rosacea: The cytokine and chemokine network Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications Role of micronutrients in skin health and function Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease Interactions between neutrophil-derived antimicrobial peptides and airway epithelial cells Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea Cathelicidins in the Tasmanian devil (Sarcophilus harrisii)Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells.Alarmins: awaiting a clinical response The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth Intestinal mucus affinity and biological activity of an orally administered antibacterial and anti-inflammatory peptide.Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study.Development of a novel antimicrobial peptide, AG-30, with angiogenic properties.Updates on the pathophysiology and management of acne rosacea.Citrullination alters immunomodulatory function of LL-37 essential for prevention of endotoxin-induced sepsis.Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A4 analog: Protective mechanisms and long-term effects on neurological recovery.Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes.HIF-1alpha: a master regulator of innate host defenses?Recent advances in the understanding and management of rosacea.Human cathelicidin production by the cervix Successful in vitro expansion and differentiation of cord blood derived CD34+ cells into early endothelial progenitor cells reveals highly differential gene expression Human antimicrobial proteins in ear wax.Neuroendocrine nicotinic receptor activation increases susceptibility to bacterial infections by suppressing antimicrobial peptide production Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications.Control of cutaneous antimicrobial peptides by vitamin D3.Dectin-1 is expressed in human lung and mediates the proinflammatory immune response to nontypeable Haemophilus influenzae.

P2860

Q24296488-3ABEB2AF-DF32-41E6-9820-5C7B2E8D4205 Q24306866-42C032D2-669D-4F2B-B844-5BE4A4786E30 Q24652940-BC6404F7-E819-4F16-9CD9-093C4B8F89AE Q24654981-458113DB-C025-4C59-9FBB-003151EE6091 Q26764915-56A303A3-8D9B-44C3-A733-B9B4F9F5B891 Q26765450-0B105163-53CF-4596-A13F-012F3786B28E Q26773618-BDF012CC-501A-4BDC-AC97-098D751272A1 Q26799856-BD3114A1-7EBD-4657-8359-561B36BD2F12 Q26801532-D1222E29-78DD-4B66-8421-540CBE3E67A8 Q27006576-F719FA13-A783-4B3A-9675-F82EEC2B1BB3 Q27007680-FD0B93BE-D748-4FA4-8C66-96F6E2957C85 Q27023344-369AAD57-0574-42E3-B84F-6B3F0A5B530D Q28067747-851531AF-40A7-45E6-8E4A-093D50537F4A Q28087327-2AD1298F-79D3-491D-84FE-EAD194AA4A21 Q28087656-1BB91B28-CA29-4686-938C-CEA14A6A0C8E Q28266421-9A805709-7D25-4326-836B-3CFCDD29E877 Q28297764-12C34449-9AAA-4DEF-BAE6-FB99667C37FF Q28742923-DFA732E8-6EB5-4A1E-BA55-D44771395C1B Q29042110-39A694AE-A245-41E4-ABA2-E045A8F6A3B0 Q30151971-8E305F39-D9EB-4F42-B67C-138AF7AE2013 Q30486489-7AFA66B8-9F67-4EA4-A95A-92ECF6BF55B9 Q30490685-D226EED8-9B22-419D-8A0B-964AB074A4A1 Q30523797-5B0535D5-FE65-4E88-A576-9873D61D6CA6 Q30933550-663AC2E2-65B2-4A7C-994B-D99613953D51 Q31160852-5EAD17E4-00A6-4B5C-B8C4-EC409F93C724 Q33267198-66A52F5C-5DED-4F3E-96E0-CAA19B0B9808 Q33328109-AA6ACC7A-C546-402C-A49F-576CD3B39252 Q33509787-6BB9EA26-9356-413E-BA42-C8BB4443FC01 Q33675249-C8CA8AAC-EB3B-4853-B2E8-8B2B635995F1 Q33695357-550DE6B9-70C9-4E83-8A59-E98C7563300E Q33749859-B55308D6-373E-41CB-9F49-7BFB98C5C18D Q33865949-6677E8A2-E0C5-412B-A795-5CA60D2EE547 Q33942083-D5D79D73-C2DA-4065-97F1-5509F702AD8D Q33999248-2E8B484C-3963-4768-802C-9AE53EE4F7DF Q33999277-3CCDE9E5-09A4-4668-BCA3-6EF0E6E614F4 Q34025657-4F762FA6-F865-4597-A4F1-2FD09FF33D1A Q34044895-6D6B8B65-CC8E-45B2-A9ED-4B6973F8E4B2 Q34091593-C2AE62ED-4C29-4A1D-AB55-4B71C43DCB91 Q34103404-A8BA15DC-9215-40F3-8630-79FEF390F601 Q34237838-5580DC74-9A7D-43A5-99EF-D141039DDEFE

P2860

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

http://www.wikidata.org/entity/Q34534186

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

@ast

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

@en

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

@nl

type

label

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

@ast

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

@en

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

@nl

prefLabel

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

@ast

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

@en

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

@nl

P1433

Q34534186-598EDB69-7600-4D6E-AAEF-6A7FB6FBDAC0

P1476

Q34534186-C57E436F-4B56-408F-BC65-5398BEB34ED9

P2093

Q34534186-031A58FC-C71D-400B-B733-0BE083B8DC41

Q34534186-088A4499-0E1F-4101-B600-45B5D3BC3B76

Q34534186-0F7D0E9A-DD40-4CC7-92AE-B2FFDF9CAD2B

Q34534186-18030174-E63B-4D80-9C4C-5BE5762C369D

Q34534186-25D55388-C92F-4F93-AB13-0E4FC4C98797

Q34534186-441555CF-F827-40D1-8BDE-9E08B869177A

Q34534186-4DAE2AC0-D4E8-4B52-A0C6-53FF606B1BD6

Q34534186-4FD49C55-1968-4163-88E3-DB738D5C41FC

Q34534186-54787F27-E456-4C15-BCC4-83B89C702FE3

Q34534186-5CBA002D-9887-4EC3-BFD8-DCF3B58935D4

P2860

Q34534186-023FC334-F3B0-41ED-8B6D-8CF1306C7057

Q34534186-109C060F-4254-4592-8F05-93651EDD8D56

Q34534186-128D3CF8-82BE-4BB3-959F-E4DBD0D216E0

Q34534186-1D8C8E17-3C31-4212-930C-7C20DB15C6BD

Q34534186-226D84D1-123E-4A37-B0B2-5407DEAFB126

Q34534186-2FF2FEB9-CA94-49E2-919D-4A6E502964AD

Q34534186-3CA246CF-151A-49D4-9A68-F4903D83B6B0

Q34534186-53B431FF-A98D-40F2-A634-3CD6C3CE8FBF

Q34534186-566BA72A-B516-42C2-A037-3CCDA7DB8E88

Q34534186-5F5C15F4-A8CC-4870-A4F7-E9212C7A8F28

P304

Q34534186-AC82139A-5D01-446B-90DC-1DE10F495A12

P31

Q34534186-BC08206C-B340-430E-862B-46169B317FC8

P356

Q34534186-61E58349-38C0-4B0B-81BB-8E2C56570297

Q34534186-96E868F6-A772-45D3-A6B5-2AB05A6DCFC3

P407

Q34534186-C5DBB4BF-39BE-4619-865E-330F8C0844BF

P433

Q34534186-8DF7CD43-5E0A-4C0C-B753-D356A7D86E50

P478

Q34534186-F0345EE0-BD01-40E3-B0CF-CDA98BC9B10A

P50

Q34534186-59217BCF-E704-42B2-B24B-55FC53C3468B

Q34534186-7F04DF8C-3891-4D04-A1D2-36540BE7CFCD

Q34534186-89E6405C-E92B-4AC5-8C87-3E59B534A70C

P577

Q34534186-8C8BDE43-411E-481C-978D-687442F17B4B

P698

Q34534186-FB6445B7-9559-43EA-B9CC-03A953F9DBE7

P921

Q34534186-0AC53396-AEE8-4090-AB83-E3DDEA447B7E

P932

Q34534186-19CA4BE5-38AA-419C-B200-C40CD777E34E

P356

P1433

Journal of Clinical Investigation

P1476

An angiogenic role for the human peptide antibiotic LL-37/hCAP-18

@en

P2093

Achim Pfosser

http://www.w3.org/2001/XMLSchema#string

Alexander Karl

http://www.w3.org/2001/XMLSchema#string

Christian Kupatt

http://www.w3.org/2001/XMLSchema#string

Corinna Lebherz

http://www.w3.org/2001/XMLSchema#string

Florian Krötz

http://www.w3.org/2001/XMLSchema#string

Georges von Degenfeld

http://www.w3.org/2001/XMLSchema#string

Katja Issbrücker

http://www.w3.org/2001/XMLSchema#string

Matthias Clauss

http://www.w3.org/2001/XMLSchema#string

Peter Boekstegers

http://www.w3.org/2001/XMLSchema#string

Philip Raake

http://www.w3.org/2001/XMLSchema#string

P2860

The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders

The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes

Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung

LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells

The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface

Epithelial antimicrobial peptides in host defense against infection

Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3

Defensins and host defense

The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations

Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence

P304

1665-1672

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI17545

http://www.w3.org/2001/XMLSchema#string

10.1172/JCI200317545

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Claus Vogelmeier

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12782669

http://www.w3.org/2001/XMLSchema#string

P921

P932

156109

http://www.w3.org/2001/XMLSchema#string